F A Mancarella

Unit of Internal Medicine, Department of Medical and Surgical Sciences, IRCCS "A. Gemelli" University Polyclinic Foundation, 00168 Rome, Italy.; Internal Medicine and Alcohol Related Disease Unit, Columbus-Gemelli Hospital, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

11 publications 2019 – 2024

What does F A Mancarella research?

F A Mancarella studies various aspects of liver health, especially conditions that stem from alcohol consumption. She investigates non-invasive diagnostic methods like shear wave dispersion elastography, which helps assess liver stiffness and inflammation. Additionally, she evaluates the effectiveness of current treatment options for Alcohol Use Disorder, emphasizing the importance of personalized approaches to care that consider an individual's unique characteristics. Her research also encompasses the implications of liver health during illnesses like COVID-19, particularly in patients with celiac disease.

Key findings

  • Shear wave dispersion elastography shows promise for evaluating liver stiffness in metabolic dysfunction-associated steatotic liver disease, but more research is needed for its application in alcohol-related liver disease.
  • A review of treatments for Alcohol Use Disorder highlights a combination of biological strategies targeting brain chemicals and psychological methods, suggesting that personalized treatment can significantly improve patient outcomes.
  • In a study of severe alcohol-related hepatitis, 65% of patients responded positively to steroid treatment, with higher prothrombin time levels indicating a greater likelihood of not responding.
  • Among 542 patients with celiac disease, only 0.92% tested positive for COVID-19, suggesting similar infection rates compared to the general population.

Frequently asked questions

Does Dr. Mancarella study liver diseases?
Yes, she focuses on liver conditions, particularly those related to alcohol consumption, like alcohol-related liver disease.
What treatments has Dr. Mancarella researched for alcohol use disorder?
She examines both biological and psychological treatment strategies, particularly those targeting brain chemicals to personalize care for patients.
Is Dr. Mancarella's work relevant to patients with severe alcohol-related hepatitis?
Yes, her research on prothrombin time has important implications for predicting responses to steroid treatments in these patients.
Does her research cover any impacts of COVID-19?
Yes, she studied the COVID-19 infection rates among patients with celiac disease, providing insights into their risk.
What is shear wave dispersion elastography?
It's a non-invasive test that measures liver stiffness and inflammation, which could help diagnose liver diseases.

Publications in plain English

Prothrombin time predicts steroid response in severe alcohol-related hepatitis.

2024

Liver international : official journal of the International Association for the Study of the Liver

Tarli C, Mannucci S, Vecchione M, Antonelli M, Sestito L +9 more

Plain English
This study looked at how a specific blood test, called prothrombin time (BPT), could predict whether patients with severe alcohol-related hepatitis would respond to steroid treatment. Researchers found that out of 52 patients treated with steroids, 34 (or 65%) responded positively, while higher BPT levels indicated a greater chance of not responding, with a significant risk ratio of about 3 times higher for non-responders. This finding is important because it can help doctors quickly identify patients who aren't likely to benefit from steroids and may need alternative treatments, such as evaluating them for liver transplantation. Who this helps: This helps doctors and patients with severe alcohol-related hepatitis.

PubMed

Shear Wave Dispersion Elastography in ALD and MASLD: Comparative Pathophysiology and Clinical Potential-A Narrative Review.

2024

Journal of clinical medicine

Dionisi T, Galasso L, Antuofermo L, Mancarella FA, Esposto G +5 more

Plain English
This research paper looks at the potential of a non-invasive test called shear wave dispersion elastography (SWD) for diagnosing alcohol-related liver disease (ALD) and compares it to a similar condition, metabolic dysfunction-associated steatotic liver disease (MASLD). The review found that while SWD shows promise in measuring liver stiffness and inflammation in MASLD, more work is needed to establish its effectiveness for ALD. Setting up specific guidelines for using SWD in ALD could lead to safer and cheaper diagnosis options for patients. Who this helps: Patients with alcohol-related liver disease and doctors evaluating their condition.

PubMed

Current treatments of alcohol use disorder.

2024

International review of neurobiology

Dionisi T, Di Sario G, De Mori L, Spagnolo G, Antonelli M +8 more

Plain English
This research looked at the various treatments for Alcohol Use Disorder (AUD) and found that a mix of biological and psychological strategies is essential for effective care. It highlighted new approaches targeting brain chemicals like Glutamate, which may help patients reduce alcohol use, and emphasized the need for personalized treatment based on individual factors, given the high number of people affected globally. Overall, the research suggests that tailored therapies can significantly improve outcomes for those struggling with alcohol dependence. Who this helps: This helps patients with Alcohol Use Disorder and healthcare providers in designing effective treatment plans.

PubMed

Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use.

2021

PloS one

Magro B, Zuccaro V, Novelli L, Zileri L, Celsa C +17 more

Plain English
This study focused on creating a simple tool to predict which COVID-19 patients might die while in the hospital. Researchers looked at over 2,000 patients and identified seven key risk factors, such as age and having diabetes, which help determine mortality risk. The prediction rule was found to be reliable, successfully categorizing patients at risk and is available online for doctors to use. Who this helps: This helps doctors better assess and manage COVID-19 patients in hospitals.

PubMed

COVID-19 in celiac disease: a multicentric retrospective cohort study.

2021

European review for medical and pharmacological sciences

Gasbarrini G, Dionisi T, Corazza GR, Aronico N, Cammarota G +7 more

Plain English
This study looked at how many patients with celiac disease (CD) contracted COVID-19. Out of 542 CD patients, only 5 (0.92%) tested positive for the virus, and their infection rates were similar to those in the general population. However, CD patients were tested less frequently, which might explain why their positive test rate appeared higher. Who this helps: This research helps celiac disease patients by informing them about their COVID-19 risk.

PubMed

Early oral vs parenteral nutrition in acute pancreatitis: a retrospective analysis of clinical outcomes and hospital costs from a tertiary care referral center.

2020

Internal and emergency medicine

Pagliari D, Rinninella E, Cianci R, Attili F, Franza L +7 more

Plain English
This study looked at how different types of nutrition—oral (by mouth) versus parenteral (by IV)—affect patients with acute pancreatitis. It found that patients who received oral nutrition had shorter hospital stays, lower hospitalization costs, and fewer complications compared to those who received nutrition through IV. Specifically, those on oral nutrition stayed in the hospital for fewer days and the total costs during their stay were significantly lower—over $6,000 less for patients with mild pancreatitis. Who this helps: This research benefits patients with acute pancreatitis by promoting more effective and cost-efficient treatment options.

PubMed

Anticoagulant therapy in the treatment of splanchnic vein thrombosis associated to acute pancreatitis: a 3-year single-centre experience.

2020

Internal and emergency medicine

Pagliari D, Cianci R, Brizi MG, Mancarella FA, Musso M +5 more

Plain English
This study looked at how blood-thinning medications, called anticoagulants, can help patients with splanchnic vein thrombosis (SVT), a complication of acute pancreatitis (AP). Out of 221 patients with AP, 27 (about 12%) had SVT; of those, 16 received anticoagulant therapy. The results showed that 69% of patients on anticoagulants had their blood vessels reopen, compared to only 27% of those who did not receive the treatment, indicating that anticoagulant therapy is both safe and effective for these patients. Who this helps: Patients with acute pancreatitis who develop splanchnic vein thrombosis.

PubMed

A new ultrasound score for the assessment and follow-up of chronic pancreatitis: The 'Gemelli USCP score'.

2020

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Pagliari D, Ainora ME, Brizi MG, Cintoni M, Rinninella E +8 more

Plain English
Researchers created a new scoring system using ultrasound to assess and track chronic pancreatitis, called the Gemelli USCP score. They studied 90 patients and found that this new score aligns closely with existing imaging methods and significantly correlates with vitamin deficiencies linked to pancreatic issues. This improved ultrasound score provides a simpler, non-invasive way to monitor patients with chronic pancreatitis and may lead to better management of their condition. Who this helps: This helps patients with chronic pancreatitis by offering a less invasive monitoring option.

PubMed

Clinical assessment and management of severe acute pancreatitis: a multi-disciplinary approach in the XXI century.

2019

European review for medical and pharmacological sciences

Pagliari D, Brizi MG, Saviano A, Mancarella FA, Dal Lago AA +5 more

Plain English
This study looks at how severe acute pancreatitis (AP), a serious digestive condition, is assessed and treated in hospitals today. Researchers found that a team-based approach, which includes various medical specialties working together, is more effective, especially using a step-by-step treatment method rather than jumping straight to advanced interventions. This matters because severe AP can lead to lasting health complications or death, and better management can improve patient outcomes. Who this helps: This helps patients with severe acute pancreatitis and the healthcare providers treating them.

PubMed

A Late Onset of Wernicke-Korsakoff Encephalopathy After Biliopancreatic Diversion: a Case Report.

2019

Obesity surgery

Negri M, Macerola N, Mancarella FA, Bruno C, De Leva F +6 more

PubMed

Cannabis-induced acute pancreatitis: a case report with comprehensive literature review.

2019

European review for medical and pharmacological sciences

Pagliari D, Saviano A, Brizi MG, Mancarella FA, Cannone F +4 more

Plain English
This study looked at a young man's repeated bouts of acute pancreatitis, a painful inflammation of the pancreas, and found that his daily cannabis use might have caused this condition. After his third episode, where he developed a serious complication, he was advised to stop using cannabis, and he did not have any further issues afterward. This highlights the importance of recognizing cannabis as a potential cause of acute pancreatitis so that patients can make informed choices about their health. Who this helps: This helps patients who use cannabis and may be at risk for acute pancreatitis.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.